腾讯投出一家创新药IPO，估值37亿，来自江苏扬州

Group 1 - The article discusses Tencent's investment in an innovative drug company's IPO, which is valued at 3.7 billion [1] - The company is based in Yangzhou, Jiangsu province, indicating a growing biotech sector in this region [1] - The investment reflects Tencent's strategy to diversify its portfolio and tap into the pharmaceutical industry [1]